This prospective clinical trial will evaluate PET/CT and genomic liquid biopsy based biomarkers as predictors of clinical therapeutic response to immune-checkp…

Hepatocellular Carcinoma Non-resectable

~Estimated

~$10 – $6,250

Queen's Medical CenterNCT04965454

Observational

Prospective Phase 2 Trial of Yttrium-90 Radiation Segmentectomy for Unresectable Hepatocellular Carcinoma

This is a prospective, single-blinded, single-arm, open-label Phase II trial of trans-arterial radiation segmentectomy using Yttrium-90 glass microspheres (The…

Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaHepatocellular Cancer+1 more

~Estimated

~$10 – $5,625

University of California, San FranciscoNCT07110233